strategic changes in the global pharmaceutical market
DESCRIPTION
Strategic Changes in the Global Pharmaceutical Market. Dr. Brian W Tempest www.briantempest.com Zurich, Switzerland October 2011. - PowerPoint PPT PresentationTRANSCRIPT
Hale & Tempest
Strategic Changes in the Global Pharmaceutical Market
Dr. Brian W Tempest
www.briantempest.com
Zurich, Switzerland October 2011
Hale & Tempest
Dr Brian Tempest advises Companies, Banks, High Net Worth Individuals and Investment Funds on their Strategy in the Emerging World based on his wide experience in China, Japan, South East Asia
and India where he has lived for the last decade.Brian has worked for Ranbaxy Laboratories since 1995 holding the position of Managing Director and Chief Executive Officer until 2005. He was then Chief Mentor and Non Executive Director until 2008 when he retired. He is one of the few westerners to have led a Sensex Nifty 50 Indian blue Chip MNC and as a result has a valuable insight into India. Brian has also worked for Glaxo as Regional Director
Far East and Regional Director Middle East & Africa from 1985 to 1992.Brian has worked in the Pharmaceutical Industry for the last 40 years and has managed Healthcare
businesses in North America, South America, Europe, Africa, Middle East, Australasia, China, Japan and India. He has also led many sessions at Investor Meetings held around the world.
He is now Independent Chairman of Religare Capital Markets PLC and Non Executive Director of SRL the largest Indian Diagnostic Company. Brian is an international advisor to MAPE, India and the United Nations (UNCTAD) in addition to being a member of the SCRIP Global awards panel he is on the Editorial Board of the Journal of Generic Medicines. Brian speaks at global conferences and more
information on these presentations can be found on his website www.briantempest.com.Brian has a PhD in Polymer Chemistry from Lancaster University in 1971 and in 2009 he became
Chairman of the Advisory Board for the Lancaster University Management School which ranks 4 th in the UK He is a Fellow of the Royal Society of Medicine and a Fellow of the Royal Society of
Chemistry and is a Chartered Chemist. He is now Chairman and Senior Partner of Hale & Tempest
Hale & Tempest
Generic Medicines are part of the Solution for Ageing Populations
Hale & Tempest
China/India with 37% population, 14% of wealth and most of the GDP growth
Hale & Tempest
Structural Change -
Big Pharma
Hale & Tempest
Only 21 2010 FDA New Drug Approvals Source: Fiercebiotech 22 Jan 2011
Hale & Tempest
USA DOJ Fines on Big PharmaSource: Chemistry World Jan 2011
Hale & Tempest
USA Batch RecallsSource: Deutche Bank 29 March 2011
Hale & Tempest
Approvals & Reimbursements Source: Pharmatimes UK July-August 2010
Hale & Tempest
Big Pharma Losing to Local Players Source GSK Presentation
Hale & Tempest
Emerging World Share of PharmaSource EIU, OECD, WHO, IMS, Roland Berger
Hale & Tempest
Top 8 Cos in Emerging Markets 2008
Hale & Tempest
Increasing Pace of Emerging Markets Acquisitions
Emerging Market Investor Days
March 16, 2010
December 10, 2009
July 2, 2009
Large Cap Pharma Entering Generics
(Egypt, Pakistan, Near East )
(MENA, LatAm, Asia-Pac)(Algeria)
With the slow-down of Western markets, Pharma are rapidly repositioning to focus on emerging markets for growth
Hale & Tempest
Sales Force Job Cuts in Press since 2009
Hale & Tempest
Structural Change
Generic Companies
Hale & Tempest
Asia vs. the Western Generic CompaniesSource: Factset, Religare
Hale & Tempest
Pricing PressuresSource: Watson
Hale & Tempest
European Generic Prices Source Ranbaxy
Hale & Tempest
European Generic Prices Source Ranbaxy
Hale & Tempest
USA - ANDA Growing Approval TimesSource FDA Chief M Hamburg, GpHA Conference February 2010
2005 16.3 months average
2009 26.7 months average
Around 2000 ANDAs awaiting approval
FDA explained as a result of staff shortages
Regulatory filing fees needed
Hale & Tempest
Season of Warning Letters/Import AlertsSource: Deutche Bank July 2011
Hale & Tempest
USA - Litigation Success Rates Source RBC Capital Markets January 15 2010
Patent Challenges on rise - 65 FTFs in 2009 Success rate at 48% - or 76% including deals 3 courts hold 69% with 36% success e.g. NJ 4 courts never ruled against generics e.g. NY At risk launches on the rise – 6 in 2009 Teva has 12 of the 28 at risk launches – 2002/9 Settlements on the rise – 54 in 2009 Teva accounts for a third of all settlements Authorized generics on the rise – 25 in 2009 Watson represents a fifth of all AGs
Hale & Tempest
Generic Profit Margin Profile in descending order source: Deutsche Bank July 2010
Hale & Tempest
Top 25 Global Generic CompaniesSource: Generics Bulletin 10 June 2011
Hale & Tempest
Next 24 Global Generic CompaniesSource: Generics Bulletin 10 June 2011
Hale & Tempest
Patent Expiries Source: Sandoz
Hale & Tempest
In 2016 Top 10 8 will be Biologic/RespSource: Sandoz EGA Conference 2011
Hale & Tempest
Structural Changes
Indian Pharma Companies
Hale & Tempest
WHO Pre Qualified Products
Hale & Tempest
Indian Generic FDA ANDA Approvals
Hale & Tempest
Niche TechnologySource: MAPE
Hale & Tempest
India – Share of CRAMS Market
Hale & Tempest
Lots of Opportunity for CROs in IndiaSource: clinicaltrials.gov 16 Feb 2011
Hale & Tempest
Macro Structural Changes
Hale & Tempest
Pfizer & Hisun
Hale & Tempest
Pharma Wholesaler sets up China JV UK Coop – the world’s largest consumer cooperative
GBP£10b UK company running food stores, banks, insurance, funeral
homes, travel agents, farms and pharmacies 3rd rank pharmacy chain in UK with 800 stores Owns UK pharmaceutical wholesaler Sants Opus Marketing JV with Day Lewis Pharmacy
Chain offers 113 products under Prospect brand Tianjin Tasly Sants Manufacturing JV opened
2010, “production under way” Jun 2011 With Investment GBP£20m, 200 staff
Hale & Tempest
China Pharma Industry Capex PlansSource: Stravencom
Hale & Tempest
India Pharma Industry Capex PlansSource: MAPE
Hale & Tempest
FDA DMFs from India
Hale & Tempest
FDA DMFs from China
Hale & Tempest
Chinese ANDAs
Hale & Tempest
Endangered Elements Source: Chemistry World 2011
Hale & Tempest
A New World Order is Coming